Press Releases

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

September 17, 2018

Critical Path Institute and SIGNATOPE GmbH Team Up to Advance Research on Biomarkers for Drug-induced Organ Injuries

TUCSON, Ariz. and REUTLINGEN, September 17, 2018 — Critical Path Institute’s Predictive Safety Testing Consortiu

September 6, 2018

Doris Duke Charitable Foundation Awards Grant to Critical Path Institute to Advance Therapies for Sickle Cell Disease

Contacts: Kissy Black, Critical Path Institute kissyblack@lotosnile.com, 615.298.1144 Kristin Roth-Schrefer, Communications Direct

July 26, 2018

First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti

May 7, 2018

C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

April 16, 2018

Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers

Tucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path

March 28, 2018

C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies

Tucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foun

March 24, 2018

Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis

WHO adopts ReSeqTB as bioinformatics platform for TB surveillance, enabling the global scale-up of culture-free,

January 22, 2018

Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker

Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E

January 17, 2018

C-Path welcomes Kay Holcombe to its Board of Directors

January 17, 2018 TUCSON, Ariz., January 17, 2018 — The Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to i

December 18, 2017

C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)

Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

Previous2627 28...33 Next